College Graduates Face High Unemployment Challenges
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 2 days ago
0mins
Should l Buy BLK?
Source: CNBC
- Rising Unemployment: According to the Federal Reserve Bank of New York, the unemployment rate for college graduates reached approximately 5.7% in Q4 2025, significantly higher than the overall rate of 4.2%, indicating a challenging job market for new graduates.
- Health Insurance Options: Many college graduates can remain on their parents' health insurance until age 26, which is often the least costly option; however, not all graduates have this choice, particularly those whose parents are on Medicare.
- Unemployment Benefits Eligibility: New graduates typically lack the four quarters of earnings required to qualify for state unemployment benefits, although they should still check with their state unemployment agency to confirm their eligibility.
- Student Loan Grace Period: In most cases, graduates do not need to start repaying student loans until six months after graduation, with federal options available to assist borrowers in managing upcoming repayment pressures.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy BLK?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on BLK
Wall Street analysts forecast BLK stock price to rise
10 Analyst Rating
8 Buy
2 Hold
0 Sell
Strong Buy
Current: 958.460
Low
1209
Averages
1354
High
1550
Current: 958.460
Low
1209
Averages
1354
High
1550
About BLK
BlackRock, Inc. is an investment management company. The Company provides a range of investment management and technology services to institutional and retail clients. Its diverse platform of alpha-seeking active, private markets, index and cash management investment strategies across asset classes enables the Company to tailor investment outcomes and asset allocation solutions for clients. Its product offerings include single- and multi-asset portfolios investing in equities, fixed income, alternatives, and money market instruments. Its products are offered directly and through intermediaries in a range of vehicles, including open-end and closed-end mutual funds, iShares exchange-traded funds, separate accounts, collective investment funds and other pooled investment vehicles. It also offers technology services, including the investment and risk management technology platform, Aladdin, Aladdin Wealth, eFront, and Cachematrix, as well as advisory services and solutions.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Earnings Release Date: BlackRock is set to announce its Q1 2023 earnings on April 14, with analysts anticipating an EPS of $12.09 and revenue of $6.6 billion, which will provide crucial insights into the company's financial health.
- Revenue Expectations: Analysts express optimism regarding BlackRock's revenue expectations, projecting it to reach $6.6 billion, reflecting the company's sustained strong performance in asset management despite challenges posed by market volatility.
- BCRED Fund Performance: The BCRED fund has reported its first loss in three years, raising significant concerns in the market that could impact investor confidence in BlackRock's overall investment portfolio, especially in the current economic climate.
- Analyst Rating Dynamics: Market analysts show mixed ratings and buy recommendations for BlackRock stock, indicating that while some maintain a positive outlook on its long-term growth potential, short-term market fluctuations may influence investor decisions.
See More
- Export Decline: India's textile exports from April 2025 to February 2026 totaled $29.5 billion, a slight drop from $29.8 billion the previous year, indicating the fragility of recovery in an industry aiming for $100 billion in exports by 2030.
- Rising Costs: The Iran war has driven raw material and packaging costs up, with polyester prices increasing over 40% since the conflict began, complicating companies' ability to pass costs onto customers and impacting production and profitability.
- Weak Demand: Although tariff relief from the U.S. provided temporary respite, industry leaders warn that a prolonged war could dampen U.S. consumer demand, leading to declining sales and rising inventories, posing significant challenges for retailers.
- Production Cuts: Companies like Filatex have already reduced production by 25% and are awaiting demand recovery, with widespread concerns that failure to pass on costs could lead to larger-scale production cuts, further affecting employment and economic growth.
See More
- Launch of Children's Accounts: Robinhood is partnering with the U.S. Treasury and BNY Mellon to introduce Trump Accounts, aimed at children born between 2025 and 2028, with the government providing a $1,000 seed contribution for each account, which is expected to serve as the first investment account for millions, thereby driving future growth for the company.
- Transparent Fee Structure: The accounts will have no trading commissions or management fees, with potential small management fees through ETFs in the future; Robinhood's CEO emphasizes this strategy aims to provide the lowest-cost investment options, enhancing customer loyalty.
- Significant Market Potential: As of March 31, over 4 million children have signed up for Trump Accounts, with more than 1 million eligible for the Treasury's $1,000 pilot program contribution, creating a substantial market base that will attract new users and enhance brand visibility for Robinhood.
- Innovative Government Collaboration: This marks Robinhood's first experience working with the government, acting as a subcontractor to BNY by designing the app and providing customer support; CEO Tenev expresses aspirations to make this project the best product associated with the government, furthering the company's mission of democratizing finance.
See More
- Children's Investment Account Partnership: Robinhood's collaboration with the U.S. Treasury to launch children's investment accounts will provide a $1,000 seed contribution for kids born between 2025 and 2028, likely attracting a new generation of investors and driving future growth for the company.
- Low-Cost Investment Platform: These accounts will be commission-free, with Robinhood focusing on its government partnership rather than short-term monetization, aiming to deliver the best investment experience for customers.
- Significant Market Potential: As of March 31, over 4 million children have registered for Trump accounts, with more than 1 million eligible for the Treasury's $1,000 pilot program contribution, indicating broad appeal and market demand for this initiative.
- Positive Stock Reaction: Following the announcement of the partnership with the Treasury, Robinhood's shares rose by 1%, reflecting market optimism about the collaboration, which could lead to increased user engagement and investment opportunities for the company.
See More
- AppLovin Revenue Upgrade: BTIG raised AppLovin's first-quarter revenue estimate to $1.82 billion, exceeding consensus, reflecting healthier performance from non-gaming marketers, which is expected to drive further stock price appreciation.
- Encompass Health Surge: Shares of Encompass Health jumped over 6% after the Centers for Medicare & Medicaid Services proposed a 2.4% rate increase for fiscal year 2027, indicating positive policy changes for the healthcare sector.
- Kratos Defense Rallies 8%: Jefferies upgraded Kratos from hold to buy with a 12-month price target of $85, highlighting a $14 billion opportunity pipeline in weapons that could drive over 30% compound annual growth in 2028 earnings estimates.
- Soleno Therapeutics Soars 32%: Neurocrine Biosciences announced an agreement to acquire Soleno for $53 per share, valuing the deal at approximately $2.9 billion, which will enhance Neurocrine's leadership in endocrinology and rare diseases.
See More











